 Michael Mestek
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 8 | 2014 | 2198 | 0.680 |
Why?
| | Postprandial Period | 3 | 2010 | 114 | 0.590 |
Why?
| | Cholesterol, HDL | 2 | 2008 | 201 | 0.490 |
Why?
| | Respiratory Rate | 4 | 2019 | 23 | 0.470 |
Why?
| | Oximetry | 5 | 2019 | 125 | 0.460 |
Why?
| | Triglycerides | 4 | 2010 | 520 | 0.420 |
Why?
| | Capnography | 3 | 2019 | 15 | 0.410 |
Why?
| | Vasoconstriction | 2 | 2010 | 216 | 0.360 |
Why?
| | Endothelin-1 | 2 | 2010 | 181 | 0.350 |
Why?
| | Metabolic Syndrome | 3 | 2014 | 360 | 0.310 |
Why?
| | Hyperlipidemias | 1 | 2010 | 120 | 0.310 |
Why?
| | Bone Diseases, Metabolic | 1 | 2010 | 58 | 0.300 |
Why?
| | Endothelium, Vascular | 3 | 2011 | 956 | 0.290 |
Why?
| | Overweight | 2 | 2011 | 614 | 0.270 |
Why?
| | Postmenopause | 1 | 2010 | 392 | 0.270 |
Why?
| | Monitoring, Physiologic | 4 | 2019 | 288 | 0.260 |
Why?
| | Vasodilation | 2 | 2011 | 521 | 0.260 |
Why?
| | Walking | 2 | 2008 | 542 | 0.240 |
Why?
| | Oxygen Consumption | 3 | 2009 | 718 | 0.220 |
Why?
| | Body Composition | 1 | 2008 | 693 | 0.210 |
Why?
| | Motor Activity | 1 | 2008 | 718 | 0.200 |
Why?
| | Lipid Metabolism | 1 | 2006 | 529 | 0.180 |
Why?
| | Students | 1 | 2008 | 651 | 0.180 |
Why?
| | Dietary Fats | 3 | 2009 | 308 | 0.180 |
Why?
| | Niacin | 2 | 2014 | 16 | 0.180 |
Why?
| | Body Mass Index | 3 | 2012 | 2445 | 0.170 |
Why?
| | Obesity | 3 | 2014 | 3116 | 0.160 |
Why?
| | Apnea | 1 | 2019 | 26 | 0.150 |
Why?
| | Respiratory Insufficiency | 2 | 2019 | 326 | 0.140 |
Why?
| | Deep Sedation | 1 | 2017 | 16 | 0.130 |
Why?
| | Middle Aged | 16 | 2019 | 36215 | 0.110 |
Why?
| | Aryldialkylphosphatase | 1 | 2014 | 17 | 0.110 |
Why?
| | Regional Blood Flow | 3 | 2011 | 514 | 0.100 |
Why?
| | Area Under Curve | 3 | 2009 | 331 | 0.100 |
Why?
| | Endothelin Receptor Antagonists | 2 | 2010 | 61 | 0.100 |
Why?
| | Patient Safety | 1 | 2017 | 356 | 0.100 |
Why?
| | Alcoholic Intoxication | 1 | 2013 | 76 | 0.090 |
Why?
| | Algorithms | 4 | 2019 | 1845 | 0.090 |
Why?
| | Peptides, Cyclic | 2 | 2010 | 273 | 0.090 |
Why?
| | Male | 18 | 2019 | 72842 | 0.090 |
Why?
| | Craniocerebral Trauma | 1 | 2013 | 178 | 0.080 |
Why?
| | Abdominal Fat | 1 | 2011 | 51 | 0.080 |
Why?
| | Adult | 13 | 2019 | 40777 | 0.080 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2010 | 49 | 0.080 |
Why?
| | Muscle Tonus | 1 | 2010 | 24 | 0.080 |
Why?
| | Cross-Over Studies | 3 | 2009 | 608 | 0.080 |
Why?
| | Signal Processing, Computer-Assisted | 3 | 2019 | 152 | 0.080 |
Why?
| | Prehypertension | 1 | 2010 | 27 | 0.080 |
Why?
| | Chemotaxis | 1 | 2010 | 122 | 0.080 |
Why?
| | Humans | 21 | 2019 | 145474 | 0.080 |
Why?
| | Nitroprusside | 1 | 2010 | 71 | 0.080 |
Why?
| | Plethysmography | 1 | 2010 | 104 | 0.080 |
Why?
| | Exercise Therapy | 1 | 2014 | 475 | 0.080 |
Why?
| | Vasoconstrictor Agents | 1 | 2010 | 150 | 0.070 |
Why?
| | Antihypertensive Agents | 2 | 2010 | 519 | 0.070 |
Why?
| | Acetylcholine | 1 | 2010 | 208 | 0.070 |
Why?
| | Diet Records | 1 | 2008 | 89 | 0.070 |
Why?
| | Waist-Hip Ratio | 1 | 2008 | 37 | 0.070 |
Why?
| | Southeastern United States | 1 | 2008 | 37 | 0.070 |
Why?
| | Self Disclosure | 1 | 2008 | 61 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 418 | 0.070 |
Why?
| | Hypertriglyceridemia | 1 | 2008 | 45 | 0.070 |
Why?
| | Brain Injuries | 1 | 2013 | 507 | 0.070 |
Why?
| | Dietary Carbohydrates | 1 | 2009 | 147 | 0.070 |
Why?
| | Sleep Deprivation | 1 | 2010 | 206 | 0.070 |
Why?
| | Hypolipidemic Agents | 1 | 2008 | 89 | 0.070 |
Why?
| | Anthropometry | 1 | 2008 | 206 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2010 | 449 | 0.060 |
Why?
| | Physical Endurance | 1 | 2009 | 279 | 0.060 |
Why?
| | Telomere | 1 | 2010 | 287 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2008 | 1300 | 0.060 |
Why?
| | Adiposity | 1 | 2011 | 532 | 0.060 |
Why?
| | Hospitalization | 1 | 2017 | 2460 | 0.060 |
Why?
| | Bone Density | 1 | 2010 | 487 | 0.060 |
Why?
| | Fibrinogen | 1 | 2007 | 180 | 0.060 |
Why?
| | Photoplethysmography | 2 | 2017 | 19 | 0.060 |
Why?
| | Female | 11 | 2019 | 78844 | 0.060 |
Why?
| | Universities | 1 | 2008 | 445 | 0.060 |
Why?
| | Physical Fitness | 1 | 2007 | 207 | 0.060 |
Why?
| | Stem Cells | 1 | 2010 | 628 | 0.060 |
Why?
| | School Health Services | 1 | 2008 | 221 | 0.060 |
Why?
| | Apoptosis | 2 | 2010 | 2440 | 0.050 |
Why?
| | Hemodynamics | 1 | 2010 | 1118 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2007 | 422 | 0.050 |
Why?
| | Cholesterol | 1 | 2006 | 408 | 0.050 |
Why?
| | Weight Loss | 1 | 2010 | 858 | 0.050 |
Why?
| | Insulin | 3 | 2009 | 2512 | 0.050 |
Why?
| | Wavelet Analysis | 2 | 2014 | 6 | 0.050 |
Why?
| | Energy Metabolism | 1 | 2009 | 935 | 0.050 |
Why?
| | Sex Factors | 1 | 2008 | 2105 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1996 | 0.040 |
Why?
| | Blood Pressure | 1 | 2008 | 1779 | 0.040 |
Why?
| | Reference Values | 2 | 2014 | 798 | 0.040 |
Why?
| | Vasodilator Agents | 2 | 2014 | 330 | 0.040 |
Why?
| | Cardiovascular Diseases | 2 | 2010 | 2187 | 0.040 |
Why?
| | Aging | 1 | 2010 | 1969 | 0.040 |
Why?
| | Caspase 3 | 2 | 2010 | 242 | 0.040 |
Why?
| | Oxygen | 2 | 2014 | 978 | 0.040 |
Why?
| | Time Factors | 2 | 2007 | 7123 | 0.030 |
Why?
| | Postoperative Period | 1 | 2019 | 351 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2017 | 3413 | 0.030 |
Why?
| | Bradycardia | 1 | 2017 | 61 | 0.030 |
Why?
| | Ascitic Fluid | 1 | 1995 | 15 | 0.030 |
Why?
| | Prospective Studies | 3 | 2019 | 8057 | 0.030 |
Why?
| | Inflammation | 1 | 2007 | 2878 | 0.030 |
Why?
| | Anesthesia | 1 | 2019 | 256 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 6066 | 0.030 |
Why?
| | Aged | 5 | 2019 | 26153 | 0.030 |
Why?
| | Apolipoprotein A-I | 1 | 2014 | 39 | 0.030 |
Why?
| | Peroxidase | 1 | 2014 | 168 | 0.030 |
Why?
| | Lipoproteins, HDL | 1 | 2014 | 100 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1995 | 130 | 0.030 |
Why?
| | Respiration | 1 | 2014 | 206 | 0.020 |
Why?
| | Pilot Projects | 1 | 2019 | 1891 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2017 | 713 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1997 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 1995 | 321 | 0.020 |
Why?
| | Hemoglobins | 1 | 2014 | 386 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2011 | 85 | 0.020 |
Why?
| | Obesity, Abdominal | 1 | 2011 | 47 | 0.020 |
Why?
| | Waist Circumference | 1 | 2011 | 143 | 0.020 |
Why?
| | Cytochromes c | 1 | 2010 | 53 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1747 | 0.020 |
Why?
| | Lymphocyte Count | 1 | 2010 | 164 | 0.020 |
Why?
| | Chemokine CXCL12 | 1 | 2010 | 86 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2010 | 95 | 0.020 |
Why?
| | Forearm | 1 | 2010 | 141 | 0.020 |
Why?
| | Fibrinolysis | 1 | 2011 | 164 | 0.020 |
Why?
| | Cell Separation | 1 | 2010 | 305 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 707 | 0.020 |
Why?
| | Tissue Plasminogen Activator | 1 | 2011 | 248 | 0.020 |
Why?
| | Young Adult | 3 | 2012 | 14218 | 0.020 |
Why?
| | Telomerase | 1 | 2010 | 246 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 114 | 0.020 |
Why?
| | Biomarkers | 2 | 2011 | 4295 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2010 | 552 | 0.020 |
Why?
| | Task Performance and Analysis | 1 | 2009 | 198 | 0.020 |
Why?
| | Factor Analysis, Statistical | 1 | 2008 | 291 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2028 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 1162 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2007 | 316 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2865 | 0.010 |
Why?
| | Energy Intake | 1 | 2009 | 512 | 0.010 |
Why?
| | Cell Movement | 1 | 2010 | 959 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2008 | 1266 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2009 | 560 | 0.010 |
Why?
| | Risk Factors | 2 | 2010 | 10885 | 0.010 |
Why?
| | Colorado | 1 | 2013 | 4553 | 0.010 |
Why?
| | Age Factors | 1 | 2010 | 3342 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2769 | 0.010 |
Why?
| | Cohort Studies | 1 | 2013 | 6013 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2010 | 3623 | 0.010 |
Why?
| | Health Status | 1 | 2007 | 832 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2013 | 2381 | 0.010 |
Why?
| | Blood Glucose | 1 | 2009 | 2341 | 0.010 |
Why?
| | Adolescent | 2 | 2012 | 22529 | 0.010 |
Why?
| | Peritoneal Lavage | 1 | 1995 | 8 | 0.010 |
Why?
| | Specialization | 1 | 1995 | 135 | 0.010 |
Why?
| | Medicine | 1 | 1995 | 125 | 0.010 |
Why?
| | Regression Analysis | 1 | 1995 | 1001 | 0.010 |
Why?
| | Ultrasonography | 1 | 1995 | 785 | 0.010 |
Why?
| | Hemorrhage | 1 | 1995 | 822 | 0.000 |
Why?
| | Child | 1 | 1995 | 22707 | 0.000 |
Why?
|
|
Mestek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|